|
1
|
Takaoka M: Resveratrol, a new phenolic
compound, from Veratrum grandiflorum. J Chem Society Japan.
60:1090–1100. 1939.
|
|
2
|
Frémont L: Biological effects of
resveratrol. Life Sci. 66:663–673. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Catana F, Yang Y, Roderick R and
van Breemen RB: An LC-MS method for analyzing total resveratrol in
grape juice, cranberry juice, and in wine. J Agric Food Chem.
50:431–435. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burns J, Yokota T, Ashihara H, Lean ME and
Crozier A: Plant foods and herbal sources of resveratrol. J Agric
Food Chem. 50:3337–3340. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jang M, Cai L, Udeani GO, Slowing KV,
Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta
RG, et al: Cancer chemopreventive activity of resveratrol, a
natural product derived from grapes. Science. 275:218–220. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clément MV, Hirpara JL, Chawdhury SH and
Pervaiz S: Chemopreventive agent resveratrol, a natural product
derived from grapes, triggers CD95 signaling-dependent apoptosis in
human tumor cells. Blood. 92:996–1002. 1998.PubMed/NCBI
|
|
7
|
Nakagawa H, Kiyozuka Y, Uemura Y, Senzaki
H, Shikata N, Hioki K and Tsubura A: Resveratrol inhibits human
breast cancer cell growth and may mitigate the effect of linoleic
acid, a potent breast cancer cell stimulator. J Cancer Res Clin
Oncol. 127:258–264. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garvin S, Ollinger K and Dabrosin C:
Resveratrol induces apoptosis and inhibits angiogenesis in human
breast cancer xenografts in vivo. Cancer Lett. 231:113–122. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalra N, Roy P, Prasad S and Shukla Y:
Resveratrol induces apoptosis involving mitochondrial pathways in
mouse skin tumorigenesis. Life Sci. 82:348–358. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shukla Y and Singh R: Resveratrol and
cellular mechanisms of cancer prevention. Ann N Y Acad Sci.
1215:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alfaras I, Juan ME and Planas JM:
Tans-resveratrol reduces precancerous colonic lesions in
dimethylhydrazine-treated rats. J Agric Food Chem. 58:8104–8110.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin HC, Chen YF, Hsu WH, Yang CW, Kao CH
and Tsai TF: Resveratrol helps recovery from fatty liver and
protects against hepatocellular carcinoma induced by hepatitis B
virus X protein in a mouse model. Cancer Prev Res (Phila).
5:952–962. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen K, Xu XW, Zhang RC, Pan Y, Wu D and
Mou YP: Systematic review and meta-analysis of laparoscopy-assisted
and open total gastrectomy for gastric cancer. World J
Gastroenterol. 19:5365–5376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pretz JL, Wo JY, Mamon HJ, Kachnic LA and
Hong TS: Chemoradiation therapy: Localized esophageal, gastric, and
pancreatic cancer. Surg Oncol Clin N Am. 22:511–524. 2011.
View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Radisky DC: Epithelial-mesenchymal
transition. J Cell Sci. 118:4325–4326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia H, Chen Q, Chen Y, Ge X, Leng W, Tang
Q, Ren M, Chen L, Yuan D, Zhang Y, et al: The lncRNA MALAT1 is a
novel biomarker for gastric cancer metastasis. Oncotarget.
7:56209–56218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Sun J, Wang J, Song Y, Gao P, Shi
J, Chen P and Wang Z: Long noncoding RNAs in gastric cancer:
Functions and clinical applications. Onco Targets Ther. 9:681–697.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun W, Yang Y, Xu C, Xie Y and Guo J:
Roles of long noncoding RNAs in gastric cancer and their clinical
applications. J Cancer Res Clin Oncol. 142:2231–2237. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang EB, Han L, Yin DD, Kong R, De W and
Chen J: c-Myc-induced, long, noncoding H19 affects cell
proliferation and predicts a poor prognosis in patients with
gastric cancer. Med Oncol. 31:9142014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou X, Ye F, Yin C, Zhuang Y, Yue G and
Zhang G: The interaction between MiR-141 and lncRNA-H19 in
regulating cell proliferation and migration in gastric cancer. Cell
Physiol Biochem. 36:1440–1452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang ZZ, Shen ZY, Shen YY, Zhao EH, Wang
M, Wang CJ, Cao H and Xu J: HOTAIR long noncoding RNA promotes
gastric cancer metastasis through suppression of poly r(C)-binding
protein (PCBP) 1. Mol Cancer Ther. 14:1162–1170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi
K, Gu Y and Fang G: Long non-coding RNA GHET1 promotes gastric
carcinoma cell proliferation by increasing c-Myc mRNA stability.
FEBS J. 281:802–813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han
Z, Sui H, Tang Y, Wang Y, Liu N, et al: Long non-coding RNA MALAT1
promotes tumor growth and metastasis in colorectal cancer through
binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2
complex. Br J Cancer. 111:736–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F,
Wei M, Shen J, Hou J, Gao X, et al: Long noncoding RNA MALAT-1 is a
new potential therapeutic target for castration resistant prostate
cancer. J Urol. 190:2278–2287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schmidt LH, Spieker T, Koschmieder S,
Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D,
Marra A, et al: The long noncoding MALAT-1 RNA indicates a poor
prognosis in non-small cell lung cancer and induces migration and
tumor growth. J Thorac Oncol. 6:1984–1992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding
Q, Weng H, Shu YJ, Liu TY, Jiang L, et al: MALAT1 promotes the
proliferation and metastasis of gallbladder cancer cells by
activating the ERK/MAPK pathway. Cancer Biol Ther. 15:806–814.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L,
Sun J, Cai J, Qin J, Ren J and Li Q: Resveratrol inhibits invasion
and metastasis of colorectal cancer cells via MALAT1 mediated
Wnt/β-catenin signal pathway. PLoS One. 8:e787002013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang HM, Yang FQ, Chen SJ, Che J and
Zheng JH: Upregulation of long non-coding RNA MALAT1 correlates
with tumor progression and poor prognosis in clear cell renal cell
carcinoma. Tumour Biol. 36:2947–2955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pang EJ, Yang R, Fu XB and Liu YF:
Overexpression of long non-coding RNA MALAT1 is correlated with
clinical progression and unfavorable prognosis in pancreatic
cancer. Tumour Biol. 36:2403–2407. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR and
Goel A: Metastasis-associated long non-coding RNA drives gastric
cancer development and promotes peritoneal metastasis.
Carcinogenesis. 35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang J, Su L, Chen X, Li P, Cai Q, Yu B,
Liu B, Wu W and Zhu Z: MALAT1 promotes cell proliferation in
gastric cancer by recruiting SF2/ASF. Biomed Pharmacother.
68:557–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Y, Wu Z, Yuan J, Sun L, Lin L, Huang N,
Bin J, Liao Y and Liao W: Long non-coding RNA MALAT1 promotes
gastric cancer tumorigenicity and metastasis by regulating
vasculogenic mimicry and angiogenesis. Cancer Lett. 395:31–44.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liang J, Liang L, Ouyang K, Li Z and Yi X:
MALAT1 induces tongue cancer cells' EMT and inhibits apoptosis
through Wnt/β-catenin signaling pathway. J Oral Pathol Med.
46:98–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu S, Song L, Yao H, Zhang L, Xu D, Gao F
and Li Q: MiR-375 is epigenetically downregulated by HPV-16 E6
mediated DNMT1 upregulation and modulates EMT of cervical cancer
cells by suppressing lncRNA MALAT1. PLoS One. 11:e01634602016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li J, Wang J, Chen Y, Li S, Jin M, Wang H,
Chen Z and Yu W: LncRNA MALAT1 exerts oncogenic functions in lung
adenocarcinoma by targeting miR-204. Am J Cancer Res. 6:1099–1107.
2016.PubMed/NCBI
|
|
45
|
Zhou X, Liu S, Cai G, Kong L, Zhang T, Ren
Y, Wu Y, Mei M, Zhang L and Wang X: Long non coding RNA MALAT1
promotes tumor growth and metastasis by inducing
epithelial-mesenchymal transition in oral squamous cell carcinoma.
Sci Rep. 5:159722015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kundu JK and Surh YJ: Cancer
chemopreventive and therapeutic potential of resveratrol:
Mechanistic perspectives. Cancer Lett. 269:243–261. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qadri SM, Föller M and Lang F: Inhibition
of suicidal erythrocyte death by resveratrol. Life Sci. 85:33–38.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bisht K, Wagner KH and Bulmer AC:
Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto-
and DNA-protective dietary compounds. Toxicology. 278:88–100. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gao Q, Yuan Y, Gan H and Peng Q:
Resveratrol inhibits the hedgehog signaling pathway and
epithelial-mesenchymal transition and suppresses gastric cancer
invasion and metastasis. Oncol Lett. 9:2381–2387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jing X, Cheng W, Wang S, Li P and He L:
Resveratrol induces cell cycle arrest in human gastric cancer
MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway.
Oncol Rep. 35:472–478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang Q, Wang B, Zang W, Wang X, Liu Z, Li
W and Jia J: Resveratrol inhibits the growth of gastric cancer by
inducing G1 phase arrest and senescence in a Sirt1-dependent
manner. PLoS One. 8:e706272013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sheth S, Jajoo S, Kaur T, Mukherjea D,
Sheehan K, Rybak LP and Ramkumar V: Resveratrol reduces prostate
cancer growth and metastasis by inhibiting the Akt/MicroRNA-21
pathway. PLoS One. 7:e516552012. View Article : Google Scholar : PubMed/NCBI
|
